Genetic Sudden Cardiac Death Screening Test on the Horizon MarketWatch (press release) The MHI will work with GnuBIO to develop and validate a proprietary set of clinically relevant SCD genes in its collection of SCD patients using GnuBIO's scalable desktop DNA sequencing system. The result will be a clinically validated test the can be ... |
